Lower riskDrug recall · FDA · Published February 25, 2022
Taro recalls Clotrimazole-Betamethas: Failed content uniformity in stability test
Taro Pharmaceuticals recalls 15g Clotrimazole-Betamethasone cream tubes due to failed content uniformity in stability testing. Rx-only product with specific lot number and expiration date.
“Taro recalls Clotrimazole-Betamethas: Failed content uniformity in stability test.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35206-taro-recalls-clotrimazole-betamethas-failed-content-uniformity-in-stability-test. Based on FDA recall #D-0727-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0727-2022%22&limit=1).
The FDA announced on Feb. 25, 2022, that Taro Pharmaceuticals U.S.A., Inc. recalled Clotrimazole and Betamethasone Dipropionate Cream USP due to failed content uniformity specifications. The agency said the recall was voluntary and has since been terminated.
How to tell if you have it
Brand: Taro
Product: Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 g tubes, Rx only
NDC: 51672-4048-1
Lot #: AC33883
Exp. Date: June 2023
The hazard
According to the FDA, the product failed content uniformity specifications because of an out-of-specification result for the Betamethasone Dipropionate assay of a stability sample.
Context
GovInfoNow's records show Taro Pharmaceuticals U.S.A., Inc. has 20 other recalls on record since Nov. 21, 2012. Other recent recalls include the Aug. 7, 2024, Taro Pharmaceuticals Hydrocortisone Otic Solution Recall for impurities risk and the Dec. 15, 2021, Taro Clobetasol Ointment Recall for R. Pickettii bacteria risk. Similar recent recalls of other products include the Aug. 3, 2026, Lupin Clobetasol Cream Recall for failed content uniformity and the March 25, 2026, Sun Pharmaceutical Fluocinonide Cream Recall for failed viscosity testing.
How to tell if you have this one
Check for the product name 'Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15g tubes' with lot number AC33883 and expiration date June 2023. This prescription-only cream was manufactured by Taro Pharmaceuticals Industries Ltd. in Haifa, Israel.
Brand
Taro
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number AC33883 and expiration date June 2023 on the tube label.
Where it went and when
Where it was distributed
Distributed in New York.
Listed by the agency
Not listed
FDA distribution: “Product was distributed to one retail consignee in NY.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New York.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0727-2022 (February 25, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0727-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.